Role of chemokines in the biology of natural killer cells

Journal of Leukocyte Biology

Volumn 71, Issue 2, 2002, Pages 173-183

  Robertson, Michael J ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Bone Marrow and Stem Cell Transplantation Program   (United States)

Author keywords

Chemotaxis; Cytotoxicity; Proliferation

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CX3C CHEMOKINE; INTERLEUKIN 8; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; RANTES; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1BETA;

CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CELL SUBPOPULATION; CELL SURFACE; CHEMOTAXIS; CYTOLOGY; CYTOLYSIS; CYTOMEGALOVIRUS; CYTOTOXICITY; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INFECTION; LEISHMANIA MAJOR; MALIGNANT NEOPLASTIC DISEASE; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

ANIMALS; ANTIGENS, CD; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC;

CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; LEISHMANIA MAJOR; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 0036486763     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Robertson, M. J., Ritz, J. (1990) Biology and clinical relevance of human natural killer cells. Blood 76, 2421-2438.
2. Timonen, T. (1997) Natural killer cells: endothelial interactions, migration, and target cell recognition. J. Leukoc. Biol. 62, 693-701.
3. Trinchieri, G. (1989) Biology of natural killer cells. Adv. Immunol. 47, 187-376.
4. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178, 567-577.
5. Orange, J. S., Wang, B., Terhorst, C., Biron, C. A. (1995) Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182, 1045-1056.
6. Salazar-Mather, T. P., Hamilton, T. A., Biron, C. A. (2000) A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J. Clin. Investig. 105, 985-993.
7. Abbas, A. K., Murphy, K. M., Sher, A. (1996) Functional diversity of helper T lymphocytes. Nature 383, 787-793.
8. Gumperz, J. E., Parham, P. (1995) The enigma of the natural killer cell. Nature 378, 245-248.
9. Lanier, L. L. (1997) Natural killer cells: from no receptors to too many. Immunity 6, 371-378.
10. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., Moretta, L. (2001) Activating receptors and coreceptors involved in human natural killler cell-mediated cytolysis. Annu. Rev. Immunol. 19, 197-223.
11. Nagler, A., Lanier, L. L., Cwirla, S., Phillips, J. H. (1989) Comparative studies of human FcR III-positive and negative natural killer cells. J. Immunol. 143, 3183-3191.
12. Caligiuri, M. A., Zmuidzinas, A., Manley, T. J., Levine, H., Smith, K. A., Ritz, J. (1990) Functional consequences of interleukin 2 receptor expression on resting human lymphocytes: identification of a novel natural killer cell subset with high affinity receptors. J. Exp. Med. 171, 1509-1526.
13. Baume, D. M., Robertson, M. J., Levine, H., Manley, T. J., Schow, P. W., Ritz, J. (1992) Differential responses to interleukin-2 define functionally distinct subsets of human natural killer cells. Eur. J. Immunol. 22, 1-6.
14. Cooper, M. A., Fehniger, T. A., Caligiuri, M. A. (2001) The biology of human natural killer cell subsets. Trends Immunol. 22, 633-640.
15. Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Grabstein, K., Caligiuri, M. A. (1994) Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180, 1395-1403.
16. bright subset. Blood 97, 3146-3151.
17. Robertson, M. J., Caligiuri, M. A., Manley, T. J., Levine, H., Ritz, J. (1990) Human natural killer cell adhesion molecules: differential expression after activation and participation in cytolysis. J. Immunol. 145, 3194-3201.
18. Robertson, M. J., Soiffer, R. J., Wolf, S. F., Manley, T. J., Donahue, C., Young, D., Herrmann, S. H., Ritz, J. (1992) Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells is differentially regulated by NKSF. J. Exp. Med. 175, 779-788.
19. Robertson, M. J., Cameron, C., Atkins, M. B., Gordon, M. S., Lotze, M. T., Sherman, M. L., Ritz, J. (1999) Immunologic effects of interleukin 12 administered by bolus intravenous injection to patients with cancer. Clin. Cancer Res. 5, 9-16.
20. Caligiuri, M. A., Murray, C., Robertson, M. J., Wang, E., Cochran, K., Cameron, C., Schow, P., Ross, M. E., Klumpp, T. R., Soiffer, R. J., Smith, K., Ritz, J. (1993) Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J. Clin. Investig. 91, 123-132.
21. Ellis, T. M., Creekmore, S. P., McMannis, J. D., Braun, D. P., Harris, J. A., Fisher, R. I. (1988) Appearance and phenotypic characterization of circulating Leu 19+ cells in cancer patients receiving recombinant interleukin 2. Cancer Res. 48, 6597-6602.
22. Rollins, B. J. (1997) Chemokines. Blood 90, 909-928.
23. Rossi, D., Zlotnik, A. (2000) The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-242.
24. Kim, C. H., Broxmeyer, H. E. (1999) Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J. Leukoc. Biol. 65, 6-15.
25. Berger, E. A., Murphy, P. M., Farber, J. M. (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17, 657-700.
26. Christopherson II, K., Hromas, R. (2001) Chemokine regulation of normal and pathologic immune responses. Stem Cells 19, 388-396.
27. Yoshie, O., Imai, T., Nomiyama, H. (2001) Chemokines in immunity. Adv. Immunol. 78, 57-110.
28. Rollins, B. J., ed. (1999) Chemokines and Cancer, Totowa, NJ, Humana.
29. Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., Power, C. A. (2000) Nomenclature for chemokine receptors. Pharmacol. Rev. 52, 145-176.
30. Campbell, J. J., Qin, S., Unutmaz, D., Soler, D., Murphy, K. E., Hodge, M. R., Wu, L., Butcher, E. C. (2001) Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression. J. Immunol. 166, 6477-6482.
31. Chuntharapai, A., Lee, J., Hebert, C. A., Kim, K. J. (1994) Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood lymphocytes. J. Immunol. 153, 5682-5688.
32. Morohashi, H., Miyawaki, T., Nomura, H., Kuno, K., Murakami, S., Matsushima, K., Mukaida, N. (1995) Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J. Leukoc. Biol. 57, 180-187.
33. Yoneda, O., Imai, T., Goda, S., Inoue, H., Yamauchi, A., Okazaki, T., Imia, H., Yoshie, O., Bloom, E. T., Domae, N., Umehara, H. (2000) Fractalkine-mediated endothelial cell damage by NK cells. J. Immunol. 164, 4055-4062.
34. Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., Yoshie, O. (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91, 521-530.
35. Inngjerdingen, M., Damaj, B., Maghazachi, A. A. (2001) Expression and regulation of chemokine receptors in human natural killer cells, Blood 97, 367-375.
36. Taub, D. D., Sayers, T. J., Carter, C. R. D., Ortaldo, J. R. (1995) α and β Chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155, 3877-3888.
37. Nieto, M., Navarro, F., Perez-Villar, J. J., del Pozo, M. A., Gonzalez-Amaro, R., Mellado, M., Frade, J. M. R., Martinez-A. C., Lopez-Botet, M., Sanchez-Madrid, F. (1998) Role of chemokines and receptor polarization in NK-target cell interactions. J. Immunol. 161, 3330-3339.
38. Polentarutti, N., Allavena, P., Bianchi, G., Giardina, G., Basile, A., Sozzani, S., Montovani, A., Introna, M. (1997) IL-2-regulated expression of monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences. J. Immunol. 158, 2689-2694.
39. Campbell, J. J., Bowman, E. P., Murphy, K., Youngman, K. R., Siani, M. A., Thompson, D. A., Wu, L., Zlotnick, A., Butcher, E. C. (1998) 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7. J. Cell Biol. 141, 1053-1059.
40. Robertson, M. J., Williams, B. T., Christopherson II, K., Brahmi, Z., Hromas, R. (2000) Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines. Cell. Immunol. 199, 8-14.
41. Yoshida, R., Nagira, M., Imai, T., Baba, M., Tagaki, S., Tabira, Y., Akagi, J., Nomiyama, H., Yoshie, O. (1998) EB11-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC. Int. Immunol. 10, 901-910.
42. Kim, C. H., Pelus, L. M., Appelbaum, E., Johanson, K., Anzai, N., Broxmeyer, H. E. (1999) CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKβ-11/MIP-3β/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors. Cell. Immunol. 193, 226-235.
43. bright+ subset. J. Clin. Lab. Anal. 8, 443-446.
44. Allavena, P., Bianchi, G., Zhou, D., van Damme, J., Jilek, P., Sozzani, S., Mantovani, A. (1994) Induction of natural killer cell migration by monocyte chemotactic protein-1, -2, and -3. Eur. J. Immunol. 24, 3233-3236.
45. Maghazachi, A. A., Skalhegg, B. S., Rolstad, B., Al-Aoukaty, A. (1997) Interferon-inducible protein-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins. FASEB J. 11, 765-774.
46. o) protein. J. Immunol. 150, 1524-1534.
47. 2+ mobilization, and enzyme release. J. Immunol. 156, 322-327.
48. Al-Aoukaty, A., Schall, T. J., Maghazachi, A. (1996) Differential coupling of CC chemokine receptors to multiple heterotrimeric G proteins in human interleukin-2-activated natural killer cells. Blood 87, 4255-4260.
49. Romagnani, P., Annunziato, F., Lazzeri, E., Cosmi, L., Beltrame, C., Lasagni, L., Galli, G., Francalanci, M., Manetti, R., Marra, F., Vanini, V., Maggi, E., Romagnani, S. (2001) Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) αβ+ CD8+ single-positive T cells, TCR γδ+ T cells, and natural killer-type cells in human thymus. Blood 97, 601-607.
50. Bianchi, G., Sozzani, S., Zlotnick, A., Mantovani, A., Allavena, P. (1996) Migratory response of human natural killer cells to lymphotactin. Eur. J. Immunol. 26, 3238-3241.
51. bright natural killer cells via the actions of monocyte inflammatory protein 1α. J. Exp. Med. 193, 1199-1212.
52. Inngjerdingen, M., Damaj, B., Maghazachi, A. A. (2000) Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J. Immunol. 164, 4048-4054.
53. Godiska, R., Chantry, D., Raport, C. J., Sozzani, S., Allavena, P., Leviten, D., Mantovani, A., Gray, P. W. (1997) Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J. Exp. Med. 185, 1595-1604.
54. Hedrick, J. A., Saylor, V., Figueroa, D., Mizoue, L., Xu, Y., Menon, S., Abrams, J., Handel, T., Zlotnick, A. (1997) Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J. Immunol. 158, 1533-1540.
55. Salazar-Mather, T. P., Orange, J. S., Biron, C. A. (1998) Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J. Exp. Med. 187, 1-14.
56. Grimm, E. A., Mazumder, A., Zhang, H. Z., Rosenberg, S. A. (1982) Lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155, 1823-1841.
57. Taub, D. D., Ortaldo, J. R., Turcoviski-Corrales, S. M., Key, M. L., Longo, D. L., Murphy, W. J. (1996) β Chemokines costimulate lymphocyte cytolysis, proliferation, and cytokine production. J. Leukoc. Biol. 59, 81-89.
58. + cells. Eur. J. Immunol. 26, 315-319.
59. Doherty, P. C. (1993) Cell-mediated cytotoxicity. Cell 75, 607-612.
60. Robertson, M. J., Manley, T. J., Donahue, C., Levine, H., Ritz, J. (1993) Costimulatory signals are required for optimal proliferation of human natural killer cells. J. Immunol. 150, 1705-1714.
61. Robertson, M. J., Cameron, C., Lazo, S., Cochran, K. J., Voss, S. D., Ritz, J. (1997) Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals. Nat. Immunol. 15, 213-226.
62. Voss, S. D., Daley, J., Ritz, J., Robertson, M. J. (1998) Participation of the CD94 receptor complex in costimulation of human natural killer cells. J. Immunol. 160, 1618-1626.
63. Nandi, D., Gross, J. A., Allison, J. P. (1994) CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 152, 3361-3369.
64. Rabinowich, H., Sedlmayr, P., Herberman, R. B., Whiteside, T. L. (1991) Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells. Cell. Immunol. 135, 454-470.
65. Fehniger, T. A., Herbein, G., Yu, H., Para, M. I., Bernstein, Z. P., O'Brien, W. A., Caligiuri, M. A. (1998) Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. J. Immunol. 161, 6433-6438.
66. Oliva, A., Kinter, A. L., Vaccarezza, M., Rubbert, A., Catanzaro, A., Moir, S., Monaco, J., Ehler, L., Mizell, S., Jackson, R., Li, Y., Romano, J. W., Fauci, A. S. (1998) Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J. Clin. Investig. 102, 223-231.
67. Andrew, D. P., Chang, M. S., McNinch, J., Wathen, S. T., Rihanek, M., Tseng, J., Spellberg, J. P., Elias III, C. G. (1998) STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J. Immunol. 161, 5027-5038.
68. Fehniger, T. A., Shah, M. H., Turner, M. J., VanDeusen, J. B., Whitman, S. P., Cooper, M. A., Suzuki, K., Wechser, M., Goodsaid, F., Caligiuri, M. A. (1999) Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162, 4511-4520.
69. Bluman, E. M., Bartynski, K. J., Avalos, B. R., Caligiuri, M. A. (1996) Human natural killer cells produce abundant macrophage inflammatory protein-1α in response to monocyte-derived cytokines. J. Clin. Investig. 97, 2722-2727.
70. Henneman, B., Tam, Y. K., Tonn, T., Klingemann, H-G. (1999) Expression of SCM-1α/lymphotactin and SCM-1β in natural killer cells is upregulated by IL-2 and IL-12. DNA Cell Biol. 18, 565-571.
71. bright natural killer cells in the human early pregnancy decidua. Biochem. Biophys. Res. Comm. 200, 378-383.
72. Kubin, M., Cassiano, L., Chalupny, J., Chin, W., Cosman, D., Fanslow, W., Mullberg, J., Rousseau, A-M., Ulrich, D., Armitage, R. (2001) ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur. J. Immunol. 31, 1428-1437.
73. Ortaldo, J. J., Bere, E. W., Hodge, D., Young, H. A. (2001) Activating Ly-49 NK receptors: central role in cytokine and chemokine production. J. Immunol. 166, 4994-4999.
74. Cosman, D., Mullberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., Chalupny, N. J. (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through NKG2D receptor. Immunity 14, 123-133.
75. Mainiero, F., Soriani, A., Stippoli, R., Jacobelli, J., Gismondi, A., Piccoli, M., Frati, L., Santoni, A. (2000) RAC1/p38 MAPK signaling pathway controls β1 integrin-induced interleukin-8 production in human natural killer cells. Immunity 12, 7-16.
76. Somersalo, K., Carpen, O., Saksela, E. (1994) Stimulated natural killer cells secrete factors with chemotactic activity, including NAP-1/IL-8, which supports VLA-4- and VLA-5-mediated migration of T lymphocytes. Eur. J. Immunol. 24, 2957-2965.
77. Forster, R., Schubel, A., Breiffeld, D., Kremmer, E., Renner-Muller, I., Wolf, E., Lipp, M. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23-33.
78. Mahalingam, S., Farber, J. M., Karupiah, G. (1999) The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo. J. Virol. 73, 1479-1491.
79. Park, J-W., Gruys, M. E., McCormick, K., Lee, J-K., Subleski, J., Wigginton, J. M., Fenton, R. G., Wang, J-M., Wiltrout, R. H. (2001) Primary hepatocytes from mice treated with IL-2/IL-12 produce T cell chemoattractant activity that is dependent on monokine induced by IFN-γ (Mig) and chemokine responsive to γ-2 (Crg-2). J. Immunol. 166, 3763-3770.
80. Reiner, S. L., Zheng, S., Wang, Z-E., Stowring, L., Locksley, R. M. (1994) Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J. Exp. Med. 179, 447-456.
81. Scharton-Kersten, T., Afonso, L. C. C., Wysocka, M., Trinchieri, G., Scott, P. (1995) IL-12 is required for natural killer cell activation and subsequent T helper 1 development in experimental Leishmaniasis. J. Immunol. 154, 5320-5330.
82. Vester, B., Muller, K., Solbach, W., Laskay, T. (1999) Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infect. Immun. 67, 3155-3159.
83. Robertson, M. J., Ritz, J. (1996) Interleukin 12: basic biology and potential applications in cancer treatment. The Oncologist 1, 93-102.
84. Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Storkus, W. J., Lotze, M. T. (1994) Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153, 1697-1706.
85. Brunda, M. J., Luistro, L., Hendrzak, J. A., Fountoulakis, M., Garotta, G., Gately, M. K. (1995) Role of interferon-γ in mediating the antitumor efficacy of interleukin-12. J. Immunother. 17, 71-77.
86. Tannenbaum, C. S., Tubbs, R., Armstrong, D., Finke, J., Bukowski, R. M., Hamilton, T. A. (1998) The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J. Immunol. 161, 927-932.
87. Coughlin, C. M., Salhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Liu, L., Laio, F., Farber, J. M., Pestka, S., Trinchieri, G., Lee, W. M. F. (1998) Tumor cell responses to IFN-γ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. Immunity 9, 25-34.
88. Sgadari, C., Angiolillo, A. L., Tosato, G. (1996) Inhibition of angiogenesis by interleukin-12 is mediated by interferon-inducible protein 10. Blood 87, 3877-3882.
89. Yao, L., Sgadari, C., Furuke, K., Bloom, E. T., Teruya-Feldstein, J., Tosato, G. (1999) Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood 93, 1612-1621.
90. Siegel, J. P., Puri, R. K. (1991) Interleukin-2 toxicity. J. Clin. Oncol. 9, 694-704.
91. Cornetta, K. G., Robertson, M. J. (2000) Basic principles of gene therapy: basic principles and safety considerations. In Principles and Practice of the Biologic Therapy of Cancer (S. A. Rosenberg, ed.), Philadelphia, Lippincott, Williams and Wilkins, 733-747.
92. Vieweg, J., Gilboa, E. (1995) Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment. Cancer Investig. 13, 193-201.
93. Vicari, A. P., Ait-Yahia, S., Chemin, K., Mueller, A., Zlotnik, A., Caux, C. (2000) Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms. J. Immunol. 165, 1992-2000.
94. Soto, H., Wang, W., Strieter, R. M., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Hedrick, J., Zlotnick, A. (1998) The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. USA 95, 8205-8210.
95. Braun, S. E., Chen, K., Foster, R. G., Orchard, P. J., Kim, C. H., Hromas, R., Kaplan, M. H., Broxmeyer, H. E., Cornetta, K. (2000) The CC chemokine CKβ-11/MIP-3β/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells. J. Immunol. 164, 4025-4031.
96. Nomura, T., Hasegawa, H., Kohno, M., Sasaki, M., Fujita, S. (2001) Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine, EBI-1-ligand chemokine and stromal cell-derived factor-1α chemokine genes. Int. J. Cancer 91, 597-606.
97. Manome, Y., Wen, P. Y., Hershowitz, A., Tanaka, T., Rollins, B. J., Kufe, D. W., Fine, H. A. (1995) Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors. Cancer Immunol. Immunother. 41, 227-235.
98. Rollins, B. J., Sunday, M. E. (1991) Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell. Biol. 11, 3125-3131.
99. Nokihara, H., Yanagawa, H., Nishioka, Y., Yano, S., Mukaida, N., Matsushima, K., Sone, S. (2000) Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice. Cancer Res. 60, 7002-7007.
100. dim NK cell subsets. J. Immunol. 161, 400-408.
101. Andre, P., Spertini, O., Guia, S., Rihet, P., Dignat-George, F., Brailly, H., Sampol, J., Anderson, P. J., Vivier, E. (2000) Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin. Proc. Natl. Acad. Sci. USA 97, 3400-3405.
102. Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., Williams, L. T. (1998) A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA 95, 258-263.
103. Rossi, D. L., Vicari, A. P., Franz-Bacon, K., McClanahan, T. K., Zlotnick, A. (1997) Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3α and MIP-β3. J. Immunol. 158, 1033-1036.
104. Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., Mackay, C. R. (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Investig. 101, 746-753.
105. Maghazachi, A. A., Al-Aoukaty, A., Schall, T. J. (1994) C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. J. Immunol. 153, 4969-4977.
106. Robertson, M. J., Cochran, K. J., Cameron, C., Le, J-M., Tantravahi, R., Ritz, J. (1996) Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 24, 406-415.